Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
- PMID: 34778276
- PMCID: PMC8582316
- DOI: 10.3389/fcell.2021.770243
Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
Abstract
[This corrects the article DOI: 10.3389/fcell.2021.695900.].
Keywords: amyotrophic lateral sclerosis; biomaterials; cell therapy; conditioned medium; exosomes; mesenchymal stem cells; neurodegenerative diseases; spinal cord injury.
Copyright © 2021 Sykova, Cizkova and Kubinova.
Erratum for
-
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.Front Cell Dev Biol. 2021 Jul 6;9:695900. doi: 10.3389/fcell.2021.695900. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34295897 Free PMC article. Review.
References
-
- Jendelová P., Herynek V., Urdzíková L., Glogarová K., Kroupová J., Andersson B., et al. . (2004). Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res. 76, 232–243. 10.1002/jnr.20041 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
